11 August 2022 · Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk
11 August 2022 · Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration